Unbounded future with AI
AI For A Better Tomorrow
In SenseTime, lead a fulfilling work life, live happily, and grow without worries.
SenseTime gives everyone an opportunity to learn and grow. In this industry (Artificial Intelligence) which is relatively new but fiercely competitive, SenseTime through its efforts has proven itself to be at the top of its class. This is because the technology that we developed is designed with the genuine intent to improve the lives of our customers.
Head of Gaming & Tourism
“Integrity, Commitment, Perseverance, Innovation and Collaboration” are shared values and beliefs of SenseTime employees, it is our code of conduct and inner DNA. The "Black Sheep" culture represents innovation and distinction. The desire to pursue win-win platforms and the courage and confidence to become the first in the world.
Integrity: Impartial | Righteous
Commitment: Trustworthy | Sincere
Perseverance: Unprejudiced | Perseverant
Innovation: Responsible | Innovative
Collaboration: Unity | Coherent
SenseTime provides an excellent career development system, catering to the needs of young employees who are looking for self-development and growth, providing employees with targeted and differentiated training programs, including a flexible internal transfer system, diversified development paths, and the opportunity to work globally. Employees can rely on the broad platform provided by the company to combine personal development goals with available opportunities, providing themselves with multiple choices.
An exciting opportunity for Singapore citizens and/or Singapore Permanent Residents (PRs) to hone their Research & Development (R&D) skills through developing AI solutions for real-world challenges. Successful candidates will be able to work at SenseTime while pursuing their PhD studies at a prominent local university in Singapore.
Click the link or scan the QR code below for full instructions on how to apply. Submit your application to the university and SenseTime by 31 Jan 2021 (Aug 2021 intake) / 31 Jul 2021 (Jan 2022 intake).